Verve Therapeutics to Present at the Piper Sandler Annual Virtual Healthcare Conference
Verve Therapeutics , a biotech company pioneering gene editing medicines to treat cardiovascular disease, today announced Sekar Kathiresan, M.D., co-founder and chief executive officer, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference taking place November 30-December 3, 2020.